Oncology

Oncology Review CME / CPD 

Full Course:  20 AMA PRA Category 1 Credits for CME / CEU / CPD

Short Course:  10 AMA PRA Category 1 Credits for CME / CEU / CPD

Course(s) are appropriate for:   Family Practitioners, Pediatricians, Internists, General Practitioners, Nurses, Nurse Practitioners, Physician Assistants (PA-C's)

Series 37 (ONC37) Topics Include:  Influence of Follow-Up Imaging, Side Effects of Treatment, Genetic Mutations, Treatment Combinations, Findings of the SWOG 8736 Trial, and more.

To view topic outline of the full or short course, select the Course Type (Full or Short) below:

Full Course:
ONC37
Full Course Price:
$580
Short Course:
ONC37A, ONC37B
Short Course Price:
$485
Format:
Available in Audio format.

Course Topics

Head and Neck Cancer Review

Discuss the influence of follow-up imaging regimens on outcomes in patients with tumors of the head and neck; Manage a patient with a cancer of the head and neck based on guidelines issued by the National Comprehensive Cancer Network; Offer treatment options to a patient with skin cancer who is not a candidate for surgical treatment; List factors associated with high-grade toxicity in patients with cancers of the head and neck who undergo chemoradiotherapy; Summarize findings of recent and ongoing studies investigating deescalation of primary therapy in patients with cancers of the head and neck.

New Developments in Breast Cancer

Explain the findings and implications of genetic tests to patients at risk for breast cancer; Summarize the current role of aromatase inhibitors in neoadjuvant therapy for breast cancer; Counsel a patient interested in scalp cooling during chemotherapy for breast cancer; Manage a patient with aromatase inhibitor-associated musculoskeletal symptoms; List risk factors for lymphedema in patients receiving chemotherapy for breast cancer.

Hodgkin Lymphoma/Pancreatic Cancer

Create a treatment plan for a patient with Hodgkin lymphoma based on patient-related factors and stage of disease; Manage Hodgkin lymphoma in a pregnant woman; Counsel a patient with HIV who has Hodgkin lymphoma; List and categorize emerging targeted therapies for pancreatic cancer; Recognize the role of stem cells in tumor growth.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Preserving Quality of Life

Proactively manage side effects of treatment in patients with cancers of the head and neck; Select an appropriate antidepressant for a patient with cancer; Explain safety concerns associated with in vitro fertilization to a woman about to undergo treatment for breast cancer; Counsel a patient considering freezing of embryos or eggs before treatment for cancer; Assess ovarian reserve in a woman previously treated for cancer.

Palliative Care/Plasma Cell Dyscrasias

Diagnose the etiology of nausea and vomiting; Select an appropriate pharmacologic treatment for vomiting; Safely manage neutropenic fever on an outpatient basis; Evaluate findings of recent trials that assessed the efficacy of selinexor in patients with plasma cell dyscrasias; Assess data on emerging pharmacologic treatments for amyloidosis.

Guest Lectures from the 11th International Symposium on Regional Cancer Therapies

Explain the role of targeted therapies in the treatment of mucinous neoplasms of the appendix; Identify mutations that confer a poor prognosis in patients with peritoneal mesothelioma; Counsel a patient considering hepatic artery infusion for metastatic colorectal cancer; Use a protocol for hepatic artery infusion that minimizes risk for severe complications; Manage care of a patient undergoing adjuvant treatment with hepatic artery infusion.

Highlights from the 14th International Ultmann Chicago Lymphoma Symposium, Part 1

Counsel patients beginning ibrutinib therapy for chronic lymphocytic leukemia about possible adverse effects; Recognize factors that predict outcomes in patients receiving front-line chemoimmunotherapy for chronic lymphocytic leukemia; Select appropriate candidates for novel therapies to manage diffuse large B-cell lymphoma; Summarize the findings of the CORAL study of patients with relapsed or refractory diffuse large B-cell lymphoma; Choose appropriate immunotherapy for patients with diffuse large B-cell lymphoma.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Radiation Oncology/Metastatic Renal Cell Carcinoma

Optimize treatment of cancer by combining radiation therapy with chemotherapy or targeted therapies; Consider new techniques for radiation therapy that minimize exposure to radiation and improve long-term outcomes; Identify patient factors that predict prognosis in metastatic renal cell carcinoma; Select systemic therapy for patients with renal cell carcinoma based on performance status, comorbidities, disease characteristics, and goals of treatment; Cite evidence on the potential role of immunotherapy in the treatment of metastatic renal cell carcinoma.

Cancer of the Colon and Rectum

Identify inherited colon cancer syndromes and the associated genetic mutations, morphologic characteristics, testing strategies, and risks for colonic and extracolonic cancers; Use hospital performance measures to assess quality of care for colorectal surgery; Choose appropriate candidates to undergo multivisceral resection; Plan the management of locally advanced and recurrent rectal cancer; . Apply the genomic analysis of colorectal cancer to clinical practice.

Highlights from the 14th International Ultmann Chicago Lymphoma Symposium, Part 2

Summarize the findings of the SWOG 8736 trial; Treat a patient with limited-stage diffuse large B-cell lymphoma; List important prognostic factors in patients with Waldenstr?m macroglobulinemia; Differentiate between patients with Waldenstr?m macroglobulinemia who need treatment and those who may be observed; Identify patients with Waldenstr?m macroglobulinemia who are likely to respond to ibrutinib.

Head and Neck Cancer Review

Discuss the influence of follow-up imaging regimens on outcomes in patients with tumors of the head and neck; Manage a patient with a cancer of the head and neck based on guidelines issued by the National Comprehensive Cancer Network; Offer treatment options to a patient with skin cancer who is not a candidate for surgical treatment; List factors associated with high-grade toxicity in patients with cancers of the head and neck who undergo chemoradiotherapy; Summarize findings of recent and ongoing studies investigating deescalation of primary therapy in patients with cancers of the head and neck.

Hodgkin Lymphoma/Pancreatic Cancer

Create a treatment plan for a patient with Hodgkin lymphoma based on patient-related factors and stage of disease; Manage Hodgkin lymphoma in a pregnant woman; Counsel a patient with HIV who has Hodgkin lymphoma; List and categorize emerging targeted therapies for pancreatic cancer; Recognize the role of stem cells in tumor growth.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Preserving Quality of Life

Proactively manage side effects of treatment in patients with cancers of the head and neck; Select an appropriate antidepressant for a patient with cancer; Explain safety concerns associated with in vitro fertilization to a woman about to undergo treatment for breast cancer; Counsel a patient considering freezing of embryos or eggs before treatment for cancer; Assess ovarian reserve in a woman previously treated for cancer.

Guest Lectures from the 11th International Symposium on Regional Cancer Therapies

Explain the role of targeted therapies in the treatment of mucinous neoplasms of the appendix; Identify mutations that confer a poor prognosis in patients with peritoneal mesothelioma; Counsel a patient considering hepatic artery infusion for metastatic colorectal cancer; Use a protocol for hepatic artery infusion that minimizes risk for severe complications; Manage care of a patient undergoing adjuvant treatment with hepatic artery infusion.

Cancer of the Colon and Rectum

Identify inherited colon cancer syndromes and the associated genetic mutations, morphologic characteristics, testing strategies, and risks for colonic and extracolonic cancers; Use hospital performance measures to assess quality of care for colorectal surgery; Choose appropriate candidates to undergo multivisceral resection; Plan the management of locally advanced and recurrent rectal cancer; . Apply the genomic analysis of colorectal cancer to clinical practice.

New Developments in Breast Cancer

Explain the findings and implications of genetic tests to patients at risk for breast cancer; Summarize the current role of aromatase inhibitors in neoadjuvant therapy for breast cancer; Counsel a patient interested in scalp cooling during chemotherapy for breast cancer; Manage a patient with aromatase inhibitor-associated musculoskeletal symptoms; List risk factors for lymphedema in patients receiving chemotherapy for breast cancer.

Palliative Care/Plasma Cell Dyscrasias

Diagnose the etiology of nausea and vomiting; Select an appropriate pharmacologic treatment for vomiting; Safely manage neutropenic fever on an outpatient basis; Evaluate findings of recent trials that assessed the efficacy of selinexor in patients with plasma cell dyscrasias; Assess data on emerging pharmacologic treatments for amyloidosis.

Highlights from the 14th International Ultmann Chicago Lymphoma Symposium, Part 1

Counsel patients beginning ibrutinib therapy for chronic lymphocytic leukemia about possible adverse effects; Recognize factors that predict outcomes in patients receiving front-line chemoimmunotherapy for chronic lymphocytic leukemia; Select appropriate candidates for novel therapies to manage diffuse large B-cell lymphoma; Summarize the findings of the CORAL study of patients with relapsed or refractory diffuse large B-cell lymphoma; Choose appropriate immunotherapy for patients with diffuse large B-cell lymphoma.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Radiation Oncology/Metastatic Renal Cell Carcinoma

Optimize treatment of cancer by combining radiation therapy with chemotherapy or targeted therapies; Consider new techniques for radiation therapy that minimize exposure to radiation and improve long-term outcomes; Identify patient factors that predict prognosis in metastatic renal cell carcinoma; Select systemic therapy for patients with renal cell carcinoma based on performance status, comorbidities, disease characteristics, and goals of treatment; Cite evidence on the potential role of immunotherapy in the treatment of metastatic renal cell carcinoma.

Highlights from the 14th International Ultmann Chicago Lymphoma Symposium, Part 2

Summarize the findings of the SWOG 8736 trial; Treat a patient with limited-stage diffuse large B-cell lymphoma; List important prognostic factors in patients with Waldenstr?m macroglobulinemia; Differentiate between patients with Waldenstr?m macroglobulinemia who need treatment and those who may be observed; Identify patients with Waldenstr?m macroglobulinemia who are likely to respond to ibrutinib.

Additional Information

Additional Continuing Medical Education options available:

Other courses of interest may include:  SurgeryFamily PracticeInternal MedicineObesity and Nutrition.

If you have taken the current Oncology CME / CPD Review listed above or if you are seeking additional credits, please visit: Medical Courses Coming Soon There you will find abbreviated listings of additional courses available related to this specialty and courses that are soon to be released.

For over 30 years, ASI has provided Continuing Medical Education, CME & CEU and Continuing Professional Development Education (CPD) for physicians and allied professionals in Oncology plus over 40 other specialties and subspecialties.  Lectures are recorded annually at the top seminars and conferences to provide the most current medical education to our clients.